Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+10.4%
5Y CAGR+8.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+10.4%/yr
vs +0.7%/yr prior
5Y CAGR
+8.7%/yr
Consistent
Acceleration
+9.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $790.01M | +8.4% |
| 2024 | $728.47M | +10.9% |
| 2023 | $656.84M | +11.8% |
| 2022 | $587.36M | -1.7% |
| 2021 | $597.81M | +14.8% |
| 2020 | $520.83M | -7.8% |
| 2019 | $564.68M | -1.2% |
| 2018 | $571.50M | +31.2% |
| 2017 | $435.51M | +24.8% |
| 2016 | $349.09M | - |